BASF increases prices for Vitamin E and A feed grade

14-Nov-2013 - Germany

Other news from the department price development

Most read news

More news from our other portals

Last viewed contents

Cell Medica granted Orphan Drug designation for novel cellular therapy

Drug costs vary by more than 600% in study of 10 high-income countries

Drug costs vary by more than 600% in study of 10 high-income countries

Are the high prices of cancer drugs justified? - Does the cost correspond to the particular drug’s effectiveness in combating the disease?

Are the high prices of cancer drugs justified? - Does the cost correspond to the particular drug’s effectiveness in combating the disease?

NextPharma inaugurates new production facility for liquid pharmaceuticals in Limay, France - "This project reflects our commitment to bringing the production of essential medicines back to France..."

NextPharma inaugurates new production facility for liquid pharmaceuticals in Limay, France - "This project reflects our commitment to bringing the production of essential medicines back to France..."

Spanish startup receives investment for novel disinfection method against “killer fungus” - The UJI spin-off Molecular Sustainable Solutions receives an investment from BeAble Capital to boost its disinfection and sterilization methods

Spanish startup receives investment for novel disinfection method against “killer fungus” - The UJI spin-off Molecular Sustainable Solutions receives an investment from BeAble Capital to boost its disinfection and sterilization methods

Merck Opens Climate-Neutral €150 Million Manufacturing Facility in Ireland - The Blarney Business Park facility is part of Merck’s largest Life Science investment to date

Merck Opens Climate-Neutral €150 Million Manufacturing Facility in Ireland - The Blarney Business Park facility is part of Merck’s largest Life Science investment to date

Simtra BioPharma Solutions expands U.S. manufacturing capacity for injectable medicines - Simtra positioned to become the first CDMO to offer commercial-scale drug product manufacturing of antibody-drug conjugates in the United States

Simtra BioPharma Solutions expands U.S. manufacturing capacity for injectable medicines - Simtra positioned to become the first CDMO to offer commercial-scale drug product manufacturing of antibody-drug conjugates in the United States

CureVac Receives Positive Validity Decision from European Patent Office in Litigation Against BioNTech SE

CureVac Receives Positive Validity Decision from European Patent Office in Litigation Against BioNTech SE

ChatGPT grows insect-toxic genetically engineered plant - Blind spot in the EU draft law on genetic engineering

ChatGPT grows insect-toxic genetically engineered plant - Blind spot in the EU draft law on genetic engineering

Commission launches new strategy to make Europe a global leader in life sciences by 2030

Commission launches new strategy to make Europe a global leader in life sciences by 2030

CureVac Announces Resolution of Patent Litigation with Pfizer/BioNTech - BioNTech’s acquisition of CureVac will be implemented as planned

CureVac Announces Resolution of Patent Litigation with Pfizer/BioNTech - BioNTech’s acquisition of CureVac will be implemented as planned

Ibidi Awarded With the German bAV Prize 2023

Ibidi Awarded With the German bAV Prize 2023